The nation’s top drug regulator, Richard Pazdur, has decided to retire three weeks after taking the job, according to two people familiar with his decision who spoke on the condition of anonymity to ...

Weeks after being named head of CDER, Pazdur has submitted paperwork to step down at the end of the month, exacerbating what’s already been a turbulent year at the FDA.

Longtime FDA oncology leader and newly appointed Center for Drug Evaluation and Research director Richard Pazdur has filed ...